Showing results (211-220 of 260) with videos related to

Sort By:
Pageof 26
International Journal of Antimicrobial Agents|December 4, 2022
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of critically ill renal patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumoniaMilo Gatti, Renato Pascale, Pier Giorgio Cojutti, et al.
Pharmaceutics|August 26, 2022
Relationship between Pharmacokinetic/Pharmacodynamic Target Attainment and Microbiological Outcome in Critically Ill COVID-19 Patients with Documented Gram-Negative Superinfections Treated with TDM-Guided Continuous-Infusion MeropenemMaria Sanz Codina, Milo Gatti, Carla Troisi, et al.
Antibiotics (Basel, Switzerland)|November 27, 2021
Assessment of a PK/PD Target of Continuous Infusion Beta-Lactams Useful for Preventing Microbiological Failure and/or Resistance Development in Critically Ill Patients Affected by Documented Gram-Negative InfectionsMilo Gatti, Pier Giorgio Cojutti, Renato Pascale, et al.
Frontiers in Pharmacology|December 27, 2021
Impact of Maximizing Css/MIC Ratio on Efficacy of Continuous Infusion Meropenem Against Documented Gram-Negative Infections in Critically Ill Patients and Population Pharmacokinetic/Pharmacodynamic Analysis to Support Treatment OptimizationPier Giorgio Cojutti, Milo Gatti, Matteo Rinaldi, et al.
The Journal of Antimicrobial Chemotherapy|June 3, 2026
Likelihood of aggressive PK/PD target attainment of continuous-infusion beta-lactams during the first week of treatment of febrile neutropenia: findings from a 1-year prospective, monocentric study in onco-haematological patientsPier Giorgio Cojutti, Alice Toschi, Zeno Pasquini, et al.
Frontiers in Pharmacology|October 14, 2021
A Proof of Concept of the Role of TDM-Based Clinical Pharmacological Advices in Optimizing Antimicrobial Therapy on Real-Time in Different Paediatric SettingsMilo Gatti, Pier Giorgio Cojutti, Caterina Campoli, et al.
Mycoses|August 13, 2021
Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysisMilo Gatti, Matteo Rinaldi, Giuseppe Ferraro, et al.
Infection and Drug Resistance|January 6, 2021
Evaluating Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacilli: A Review of the Emerging DataDaniele Roberto Giacobbe, Eugenio Ciacco, Corrado Girmenia, et al.
International Journal of Antimicrobial Agents|June 6, 2026
Emergence of Dalbavancin Non-Susceptible Methicillin-Resistant Staphylococcus epidermidis (MRSE) in a Patient Treated With Dalbavancin prolonged therapy: Case Report, Therapeutic Drug Monitoring and Genomic CharacterizationSimone Giuliano, PierGiorgio Cojutti, Michela Bulfoni, et al.
Therapeutic Drug Monitoring|October 1, 2019
Interlaboratory Analysis of Isavuconazole Plasma Concentration Assays Among European LaboratoriesFederico Pea, Robert Krause, Carsten Müller, et al.
Pageof 26